M&A Deal Summary |
|
|---|---|
| Date | 2013-12-06 |
| Target | Abcur AB |
| Sector | Life Science |
| Buyer(s) | Amdipharm Mercury Co. - AMCo. |
| Deal Type | Add-on Acquisition |
SEARCH BY
Amdipharm Mercury (AMCo) is an international speciality pharmaceuticals company delivering high quality medicines with a customer focus in 112 territories.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 3 |
| Sector: Life Science M&A | 2 of 2 |
| Type: Add-on Acquisition M&A Deals | 2 of 3 |
| Country: Sweden M&A | 1 of 1 |
| Year: 2013 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-10-01 |
Focus Pharmaceuticals
London, United Kingdom Focus Pharmaceuticals Ltd is a generic pharmaceutical company specializing in bringing new generic products to market in the UK. |
Buy | £50M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-07-14 |
Boucher & Muir Pty
Crows Nest, Australia Boucher & Muir Pty Ltd. is a provider of medical products from vaccines to anaesthetics, as well as more typical products such as solid dose tablets and capsules. |
Buy | - |